BioScale | GenomeWeb


The company is developing a proteomic test for chronic obstructive pulmonary disease that it plans to launch in early 2018 as a CLIA-based diagnostic.

Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said in a regulatory document that it has raised $18.8 million of a targeted $38.3 million financing round.

Biotech firm BioScale presented data this week at the Society of Laboratory Automation and Screening annual meeting in Orlando demonstrating the ability of its acoustic membrane microparticle technology to quantify levels of multiple cytokines in serum and plasma.

The California Institute of Technology of Pasadena has received US Patent No. 8,354,231, "Methods and systems for detecting and/or sorting targets." The methods provided are based on the combined use of polynucleotide-encoded protein and substrate polynucleotides.

People in the News

NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.

BioScale said this week that it has appointed Martin Latterich as chief scientific officer.

By Molika Ashford
Bioscale this week presented data on the application of its acoustics-based protein detection technology to measure and quantitate the activity state of multiple kinases in the MAPK pathway.

Movers & Shakers


Vermillion announced this week that Sandra Gardiner has resigned as vice president and chief financial officer and is leaving the company to take a job with an undisclosed firm in the San Francisco Bay Area.

The drugmaker, which purchased a system in August after several months of trying out a beta version, is using it to measure pharmacodynamic biomarkers, and has found it cuts run times for such assays from a week down to as little as a day.


In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.